Analyst Research Report Snapshot


BTG plc






17 Dec 2014





Companies referenced:

Available for Immediate Download

BTG plc - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on BTG plc required for business and competitor intelligence needs - Intelligence on BTG plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about BTG plc, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: BTG is a UK-based healthcare company. The company is engaged in providing specialty pharmaceuticals, interventional medicine, and licensed products and programs. BTG’s specialty pharmaceutical products include antidotes that are used to treat snake envenomation and toxicity associated with medicines used for heart conditions and cancer. The company’s interventional medicines include interventional oncology products that are used to treat patients with liver or prostate cancer; and interventional vascular products that are used to treat patients with blood clots. The company operates in the UK, Guernsey, Germany, the US and Australia. It is headquartered in London, the UK and employs around 570 people. The company recorded revenues of £233.7 million (approximately $369.5 million) in the fiscal year ended March 2013, an increase of 18.6% over 2012. The company's operating profit was £25.7 million (approximately $40.6 million) in fiscal 2013, an increase of 29.1% over 2012. Its net profit was £16.4 million (approximately $25.9 million) in fiscal 2013, an increase of 12.3% over 2012. Reasons to Purchase: - Gain understanding of BTG plc the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess BTG plc as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on BTG plc your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.